Published in Int J Cardiol on June 24, 2008
Proteolytic regulation of epithelial sodium channels by urokinase plasminogen activator: cutting edge and cleavage sites. J Biol Chem (2015) 0.79
Epidemiology of patients hospitalised for pneumonia in 2011: a prospective multicentre cohort study. Wien Klin Wochenschr (2013) 0.75
Pulmonary hypertension, right ventricular function, and clinical outcome in acute decompensated heart failure. J Card Fail (2013) 2.66
Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res (2005) 1.70
Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype. Diabetes (2008) 1.64
Sepsis impairs alveolar epithelial function by downregulating Na-K-ATPase pump. Am J Physiol Lung Cell Mol Physiol (2011) 1.62
The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant (2005) 1.62
Fluid loss, venous congestion, and worsening renal function in acute decompensated heart failure. Eur J Heart Fail (2013) 1.60
The impact of body mass index on clinical outcomes after acute myocardial infarction. Int J Cardiol (2010) 1.57
High CO2 levels impair alveolar epithelial function independently of pH. PLoS One (2007) 1.33
Telephone follow-up improves patients satisfaction following hospital discharge. Eur J Intern Med (2008) 1.17
Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia. Crit Care (2011) 1.14
Pulmonary hypertension in hemodialysis patients: an unrecognized threat. Semin Dial (2006) 1.09
Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients. Circ Res (2005) 1.07
Double gene deletion reveals lack of cooperation between claudin 11 and claudin 14 tight junction proteins. Cell Tissue Res (2008) 1.07
Is elevated red cell distribution width a prognostic predictor in adult patients with community acquired pneumonia? BMC Infect Dis (2014) 1.05
Relation between changes in red cell distribution width and clinical outcomes in acute decompensated heart failure. Int J Cardiol (2012) 1.01
Acute renal infarction from a cardiac thrombus. Nat Clin Pract Nephrol (2007) 1.00
Lessepsian migration and tetrodotoxin poisoning due to Lagocephalus sceleratus in the eastern Mediterranean. Toxicon (2008) 0.99
Acute-on-chronic renal failure in the rat: functional compensation and hypoxia tolerance. Am J Nephrol (2006) 0.97
Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus. Thromb Res (2010) 0.94
Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation (2002) 0.93
The 1,4,5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes. Cardiovasc Res (2005) 0.93
Impact of pneumoperitoneum on renal perfusion and excretory function: beneficial effects of nitroglycerine. Surg Endosc (2008) 0.93
Induction of cardiac hypertrophy by a controlled reproducible sutureless aortocaval shunt in the mouse. J Invest Surg (2005) 0.90
Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium. Basic Res Cardiol (2010) 0.89
Endothelin-1 impairs alveolar epithelial function via endothelial ETB receptor. Am J Respir Crit Care Med (2008) 0.88
Coagulation and anticoagulation in pulmonary arterial hypertension. Isr Med Assoc J (2009) 0.88
Hyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischaemic kidney. Nephrol Dial Transplant (2008) 0.86
Antibiotic utilization prevalence: prospective comparison between two medical departments in a tertiary care university hospital. Pharmacoepidemiol Drug Saf (2004) 0.85
Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1. Am J Physiol Renal Physiol (2013) 0.85
Adherence to guidelines improves the clinical outcome of patients with acutely decompensated heart failure. Isr Med Assoc J (2009) 0.84
Gender differences in the perception of chest pain. J Pain Symptom Manage (2004) 0.83
Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome. Am J Physiol Renal Physiol (2007) 0.83
Popeye domain containing 1 (Popdc1/Bves) is a caveolae-associated protein involved in ischemia tolerance. PLoS One (2013) 0.83
Sniffing chronic renal failure in rat model by an array of random networks of single-walled carbon nanotubes. ACS Nano (2009) 0.83
Involvement of the endothelin and nitric oxide systems in the pathogenesis of renal ischemic damage in an experimental diabetic model. Life Sci (2012) 0.83
Arterio-venous access in end-stage renal disease patients and pulmonary hypertension. Ther Adv Respir Dis (2008) 0.83
Human factors-focused reporting system for improving care quality and safety in hospital wards. Hum Factors (2012) 0.82
Effects of chronic rosiglitazone treatment on renal handling of salt and water in rats with volume-overload congestive heart failure. Circ Heart Fail (2011) 0.82
Catastrophic antiphospholipid syndrome presented with abdominal, pulmonary, and bone marrow complications. Rheumatol Int (2009) 0.81
Corin: a new player in the regulation of salt-water balance and blood pressure. Curr Opin Nephrol Hypertens (2013) 0.81
Differential regulation of ET(A) and ET(B) in the renal tissue of rats with compensated and decompensated heart failure. J Cardiovasc Pharmacol (2004) 0.81
Gold nanoparticle sensors for detecting chronic kidney disease and disease progression. Nanomedicine (Lond) (2012) 0.81
Lymphangitis carcinomatosis of unknown origin presenting as severe pulmonary hypertension. Am J Med Sci (2004) 0.81
Interleukin-6 at discharge predicts all-cause mortality in patients with sepsis. Am J Emerg Med (2013) 0.81
Characterization of pulmonary venous hypertension patients with reactive pulmonary hypertension as compared to proportional pulmonary hypertension. Respiration (2011) 0.80
Renal slit diaphragm--the open zipper and the failing heart. Isr Med Assoc J (2007) 0.80
Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies. Am J Physiol Renal Physiol (2005) 0.80
Nephroprotective effects of TVP1022, a non-MAO inhibitor S-isomer of rasagiline, in an experimental model of diabetic renal ischemic injury. Am J Physiol Renal Physiol (2013) 0.80
Augmentation of endogenous dopamine production increases lung liquid clearance. Am J Respir Crit Care Med (2003) 0.80
Inhibition of diabetic nephropathy in rats by an oral antidiabetic material extracted from yeast. J Am Soc Nephrol (2006) 0.80
Kidney-ear axis. Isr Med Assoc J (2007) 0.80
Clinical and experimental pain perception is attenuated in patients with painless myocardial infarction. Pain (2007) 0.80
Pneumoperitoneum aggravates renal function in cases of decompensated but not compensated experimental congestive heart failure: role of nitric oxide. J Urol (2011) 0.79
Role of protein kinase C in the expression of endothelin converting enzyme-1. Endocrinology (2008) 0.79
Involvement of Rho kinase pathway in the mechanism of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure. Am J Physiol Heart Circ Physiol (2005) 0.79
Pharmacogenomic, physiological, and biochemical investigations on safety and efficacy biomarkers associated with the peroxisome proliferator-activated receptor-gamma activator rosiglitazone in rodents: a translational medicine investigation. J Pharmacol Exp Ther (2010) 0.79
Hyponatraemia predicts the acute (type 1) cardio-renal syndrome. Eur J Heart Fail (2013) 0.79
Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure. Am J Physiol Heart Circ Physiol (2005) 0.79
Early treatment with everolimus exerts nephroprotective effect in rats with adriamycin-induced nephrotic syndrome. Nephrol Dial Transplant (2011) 0.78
TVP1022: A Novel Cardioprotective Drug Attenuates Left Ventricular Remodeling After Ischemia/Reperfusion in Pigs. J Cardiovasc Pharmacol (2015) 0.78
Acute vasculitis with multiorgan involvement in a patient with familial Mediterranean fever. Am J Med Sci (2003) 0.78
Dilated cardiomyopathy: an unusual complication of clozapine therapy. Nat Clin Pract Cardiovasc Med (2008) 0.78
Targeting C-reactive protein levels using high-dose atorvastatin before coronary artery bypass graft surgery. Exp Clin Cardiol (2008) 0.78
Paraoxonase1 deficiency in mice is associated with hypotension and increased levels of 5,6-epoxyeicosatrienoic acid. Atherosclerosis (2012) 0.78
Renal effects of human urotensin-II in rats with experimental congestive heart failure. Nephrol Dial Transplant (2006) 0.78
Nitric oxide synthase inhibition aggravates the adverse renal effects of high but not low intraabdominal pressure. Surg Endosc (2009) 0.78
Idiopathic pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: can we be certain? Isr Med Assoc J (2011) 0.77
Role of neuropeptide Y in the regulation of kidney function. EXS (2006) 0.77
Fulminant pneumonitis: a clue to autoimmune disease. Isr Med Assoc J (2013) 0.76
Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure. J Pharmacol Exp Ther (2008) 0.76
Alveolar fluid reabsorption is increased in rats with compensated heart failure. Am J Physiol Lung Cell Mol Physiol (2006) 0.76
Vasopressin-2 receptor antagonist attenuates the ability of the lungs to clear edema in an experimental model. Am J Respir Cell Mol Biol (2012) 0.76
Urinary NGAL and KIM-1: potential association with histopathologic features in patients with renal cell carcinoma. World J Urol (2013) 0.76
Phosphodiesterase 5 inhibition protects against increased intra-abdominal pressure-induced renal dysfunction in experimental congestive heart failure. Eur J Heart Fail (2012) 0.76
Acute obstructive jaundice and chronic cirrhosis protect against the adverse renal effects of pneumoperitoneum: role of nitric oxide. Surg Endosc (2013) 0.76
Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure. J Cardiovasc Pharmacol (2004) 0.75
Correction: The Role of Angiotensin II and Cyclic AMP in Alveolar Active Sodium Transport. PLoS One (2015) 0.75
Reply to acute decompensated heart failure and pulmonary hypertension. J Card Fail (2014) 0.75
Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients. Isr Med Assoc J (2004) 0.75
Impact of hemodialysis on exhaled volatile organic compounds in end-stage renal disease: a pilot study. Nanomedicine (Lond) (2013) 0.75
Ethnic differences in population approach and experience regarding complementary-alternative medicine (CAM). Pharmacoepidemiol Drug Saf (2006) 0.75
Effects of endothelin-1 on systemic and renal hemodynamics in hypertensive-diabetic rats (CRDH), diabetic rats (CDR), and hypertensive rats (SHR). J Cardiovasc Pharmacol (2004) 0.75
Peroxisome proliferator-activated receptor alpha and alpha/gamma agonists do not cause impairment in renal function in the rat. Nephron Physiol (2010) 0.75
Patient approach and experience regarding complementary medicine: survey among hospitalized patients in a university hospital. Pharmacoepidemiol Drug Saf (2003) 0.75
Severe Coagulation Disorder and Thrombocytopenia Associated with Tigecycline - Case Report and Review of Literature. Curr Drug Saf (2017) 0.75
[Aldosterone--classic and non classic effects]. Harefuah (2002) 0.75
Bilirubin impairs intestinal regrowth following massive small bowel resection in a rat model. J Pediatr Gastroenterol Nutr (2009) 0.75
Urinary excretion of endothelin receptors ET A and ET B in hypertensive patients and normotensive subjects. Kidney Blood Press Res (2009) 0.75
Renal and systemic effects of endothelin-1 in diabetic-hypertensive rats. Clin Exp Hypertens (2011) 0.75